A phase I trial of ASN004
Phase of Trial: Phase I
Latest Information Update: 08 May 2018
At a glance
- Drugs ASN 004 (Primary)
- Indications Cancer
- Focus Adverse reactions; First in man
- 08 May 2018 According to an Asana BioSciences media release, this trial is expected to begin in 2019.
- 26 Oct 2017 New trial record
- 24 Oct 2017 This trial is expected to begin in 2018, according to an Asana BioSciences media release.